FLS
65
2
BK
74
3
GRMN
45
3
AMGN
36
-3
AKAM
59
-3
OXY
40
3
MHK
53
-9
GD
60
3
NVDA
52
2
ORLY
50
2
PPL
52
-3
DG
68
13
NDAQ
67
5
PNR
60
-5
KSS
59
-5
ZTS
10
-6
ESS
39
-5
INTU
60
8
HSY
37
2
WM
54
-3
FLS
65
2
BK
74
3
GRMN
45
3
AMGN
36
-3
AKAM
59
-3
OXY
40
3
MHK
53
-9
GD
60
3
NVDA
52
2
ORLY
50
2
PPL
52
-3
DG
68
13
NDAQ
67
5
PNR
60
-5
KSS
59
-5
ZTS
10
-6
ESS
39
-5
INTU
60
8
HSY
37
2
WM
54
-3
Financhill
Back

Plus Therapeutics, Inc. Stock Predictions

AI Powerhouse Raises Price - But Room Remains

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
46

PSTV
Plus Therapeutics, Inc.

Last Price:
$0.64
Seasonality Move:
3.95%

7 Day Trial

ALL ACCESS PASS

$ 7

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Plus Therapeutics, Inc. Stock Forecast

  • Is Plus Therapeutics, Inc. Stock Undervalued?
    The current Plus Therapeutics, Inc. [PSTV] share price is $0.66. The Score for PSTV is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • PSTV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Plus Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Plus Therapeutics, Inc. Stock Rating

Data Unavailable

Plus Therapeutics, Inc. Stock Price History

Is PSTV stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSTV is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
plustherapeutics.com

52-Week Data

52-Week High:
2.31
52-Week Low:
0.16

Prediction Charts

Market Cap:
90M
Price in USD:
0.66
Volume:
9.3M
Beta:
1.16

Technical Analysis

SMA50:
0.61
SMA100:
0.56
SMA200:
0.60
52-Wk Change:
-50.75%

Stock Predictions

  • Is Plus Therapeutics, Inc. stock public?
    Yes, Plus Therapeutics, Inc. is a publicly traded company.
  • What is the Plus Therapeutics, Inc. stock quote today?
    The Plus Therapeutics, Inc. stock price is 0.66 USD today.
  • How to buy Plus Therapeutics, Inc. stock online?
    You can buy Plus Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-14 0.51 0.51 0.53 0.50
Nov-17 0.56 0.48 0.56 0.46
Nov-18 0.48 0.51 0.52 0.48
Nov-19 0.51 0.49 0.51 0.48
Nov-20 0.55 0.49 0.56 0.48
Nov-21 0.49 0.53 0.53 0.48
Nov-24 0.55 0.58 0.59 0.53
Nov-25 0.57 0.56 0.58 0.55
Nov-26 0.57 0.60 0.63 0.57
Nov-28 0.60 0.61 0.63 0.60
Dec-1 0.61 0.58 0.61 0.55
Dec-2 0.58 0.59 0.59 0.57
Dec-3 0.59 0.60 0.60 0.57
Dec-4 0.60 0.66 0.66 0.60

Plus Therapeutics, Inc. Earnings

Data Unavailable

Plus Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.84 per share, and an increase next year of $0.09 per share.

* Plus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.